Back to All Events

Drug Use in Pregnancy: Mother and Child

Registration information coming soon!

A child’s prenatal exposure to maternal substance use during gestation is recognized as one of the most significant barriers to the child’s ultimate healthy development.  The direct biological toxicity of the drugs and the social and psychological disarray of the substance-misusing environment during gestation ultimately impede the child’s growth and development and pose a grave risk to the child’s overall well-being.  This session will address the psychosocial and neurobiological changes that occur in the pregnant woman and her developing fetus as a result of exposure to tobacco, marijuana and illicit drugs and describe maternal and neonatal outcomes in pregnancies complicated by substance misuse.

Learning objectives

At the conclusion of this session, participants will be able to:

  1. Describe the biological impact of tobacco, marijuana and illicit drugs on the developing fetal brain.

  2. List three medical effects of prenatal substance exposure on newborn outcome

  3. Discuss the impact of prenatal substance exposure on neonatal neurobehavior.

  4. Analyze the impact of prenatal substance exposure on the newborn infant’s ability to participate in a dyadic relationship with his or her foster or adoptive family.

  5. Name three strategies that can promote early attachment in the young child in foster or adoptive placement.

Previous
Previous
March 18

Building Stronger Bonds: Enhancing Parent-Child Attunement

Next
Next
May 6

Fetal Alcohol Spectrum Disorders (FASD): Understanding the Diagnosis